文献速递腹部技术与安全CT

放射组学在胃癌精准医学中的机遇与挑战

Radiomics in precision medicine for gastric cancer: opportunities and challenges.
PubMed 文献 · Eur Radiol · 2022-03-22

该系统评价纳入25项研究共10432例患者,96%从CT提取放射组学特征,7项评估疗效反应、17项评估生存关联,所有结果均显示显著关联;研究按图像挖掘分期多为II期(72%),放射组学质量评分中位44.4%,研究间异质性大、质量偏低,作者认为需标准化与协作以推动临床应用。

要点

  • 胃癌放射组学研究96%基于CT图像提取特征,主要用于预测疗效反应和生存。
  • 纳入研究均报告放射组学特征与疗效或生存显著关联,但研究设计多为II期。
  • 放射组学质量评分中位44.4%(范围0至55.6%),研究间存在广泛异质性。

核心结论

  • 胃癌放射组学研究高度异质且质量相对较低,但有望用于预测治疗反应和预后,需标准化和协作以推动临床应用。

研究设计与样本

  • 系统检索PubMed和Embase数据库自建库至2021年7月10日发表的文献。
  • 纳入25项研究共10432例患者,96%的研究从CT图像提取放射组学特征。
  • 采用图像挖掘研究的分期分类标准和放射组学质量评分(RQS)工具评估科学性和报告质量。

诊断标准与关键数值

  • 7项(28%)研究评估放射组学特征与治疗反应的关联,17项(68%)研究评估与生存的关联,1项(4%)研究同时分析两者。
  • 按图像挖掘分期分类标准,18项(72%)研究为II期,2项为发现科学,4项为0期,1项为I期。
  • 放射组学研究的RQS中位评分为44.4%(范围0至55.6%)。

局限性

  • 纳入研究在人群、肿瘤分期、治疗方案和放射组学工作流程方面存在广泛异质性。
  • 放射组学研究质量相对较低,RQS中位评分44.4%(范围0至55.6%)。
  • 作者结论指出需要努力实现标准化和协作,以将放射组学用于临床应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Radiomic features derived from routine medical images show great potential for personalized medicine in gastric cancer (GC). We aimed to evaluate the current status and quality of radiomic research as well as its potential for identifying biomarkers to predict therapy response and prognosis in patients with GC.

METHODS: We performed a systematic search of the PubMed and Embase databases for articles published from inception through July 10, 2021. The phase classification criteria for image mining studies and the radiomics quality scoring (RQS) tool were applied to evaluate scientific and reporting quality.

RESULTS: Twenty-five studies consisting of 10,432 patients were included. 96% of studies extracted radiomic features from CT images. Association between radiomic signature and therapy response was evaluated in seven (28%) studies; association with survival was evaluated in 17 (68%) studies; one (4%) study analyzed both. All results of the included studies showed significant associations. Based on the phase classification criteria for image mining studies, 18 (72%) studies were classified as phase II, with two, four, and one studies as discovery science, phase 0 and phase I, respectively. The median RQS score for the radiomic studies was 44.4% (range, 0 to 55.6%). There was extensive heterogeneity in the study population, tumor stage, treatment protocol, and radiomic workflow amongst the studies.

CONCLUSIONS: Although radiomic research in GC is highly heterogeneous and of relatively low quality, it holds promise for predicting therapy response and prognosis. Efforts towards standardization and collaboration are needed to utilize radiomics for clinical application.

KEY POINTS: • Radiomics application of gastric cancer is increasingly being reported, particularly in predicting therapy response and survival. • Although radiomics research in gastric cancer is highly heterogeneous and relatively low quality, it holds promise for predicting clinical outcomes. • Standardized imaging protocols and radiomic workflow are needed to facilitate radiomics into clinical use.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Chen, Zhang, Liu, et al. Radiomics in precision medicine for gastric cancer: opportunities and challenges. Eur Radiol. 2022. PMID: 35316364. doi:10.1007/s00330-022-08704-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。